Ceramide-induced impairment of endothelial function is prevented by CuZn superoxide dismutase overexpression

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 25, Issue 1, 2005, Pages 90-95

  Didion, Sean P ^a   Faraci, Frank M ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

Carotid artery; Genetically altered mice; Nitric oxide; Reactive oxygen species; SOD1

Indexed keywords

ACETYLCHOLINE; CERAMIDE; COPPER ZINC SUPEROXIDE DISMUTASE; ISOENZYME; MACROGOL; NITROPRUSSIDE SODIUM; PAPAVERINE; SUPEROXIDE;

ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CAROTID ARTERY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SECOND MESSENGER; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; CAROTID ARTERIES; CERAMIDES; ENDOTHELIUM; ENDOTHELIUM, VASCULAR; FEMALE; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; SUPEROXIDE DISMUTASE;

EID: 11144248484     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.0000149868.74075.5d     Document Type: Article

References (46)

1. Ballou LR, Laulederkind SJF, Rosloniec EF, Raghow R. Ceramide signaling and the immune response. Biochim Biophys Acta. 1996;1301:273-287.
2. MacKichan ML, DeFranco AL. Role of ceramide in lipopolysaccharide (LPS)-induced signaling. J Biol Chem. 1999;274:1767-1775.
3. Kim MY, Linardic C, Obeid L, Hannun Y. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma-interferon. Specific role in cell differentiation. J Biol Chem. 1991;266:484-489.
4. Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol. 2001;281:H2337-H2365.
5. Levade T, Auge N, Veldman RJ, Cuvillier O, Negre-Salvayre A, Salvayre. Spingolipid mediators in cardiovascular cell biology and pathology. Circ Res. 2001;89:957-968.
6. Chatterjee S. Sphingolipids in atherosclerois and vascular biology. Arterioscler Thromb Vasc Biol. 1998;18:1523-1533.
7. Johns DG, Osborn H, Webb RC. Ceramide: a novel cell signaling mechanism for vasodilation. Biochem Biophys Res Comm. 1997;237:95-97.
8. Auge N, Negre-Salvayre A, Salvayre R, Levade T. Sphingomylein metabolites in vascular cell signaling and atherogenesis. Prog Lipid Res. 2000;39:207-229.
9. Chatterjee SB, Dey S, Shi WY, Thomas K, Hutchins GM. Accumulation of glycosphingolipids in human atherosclerotic plaque and unaffected aorta tissues. Glycobiology. 1997;7:57-65.
10. Mukhin DN, Prokazova NV. Neutral glycosphingolipid content and composition of cells from normal and atherosclerotic human aorta. Atherosclerosis. 1992;93:173-177.
11. Schissel SL, Tweedie-Hardman J, Rapp JH, Graham G, Williams KJ, Tabas I. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. J Clin Invest. 1996;98:1455-1464.
12. Auge N, Andrieu N, Negre-Salvayre A, Thiers JC, Levade T. The spingomyelin-ceramide signaling pathway is involved in oxidized low density lipoprotein-induced cell proliferation. J Biol Chem. 1996;271:19251-19255.
13. Garner B, Priestman DA, Stocker R, Harvey DJ, Butters TD, Platt FM. Increased glycosphingolipid levels in serum and aortae of apolipoprotein E gene knockout mice. J Lipid Res. 2002;43:205-214.
14. Zhang DX, Zou AP, Li PL. Ceramide reduces endothelium-dependent vasodilatation by increasing superoxide production in small bovine coronary arteries. Circ Res. 2001;88:824-831.
15. i in rat aortic smooth muscle. Lipids. 1999;34:689-695.
16. Ca, channel activity and vascular tone in coronary arteries. Hypertension. 1999;33:1441-1446.
17. Zhang DX, Zou AP, Li PL. Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries. Am J Physiol Heart Circ Physiol. 2003;284:H605-H612.
18. Murohara T, Kugiyama K, Ohgushi M, Sugiyama S, Ohta Y, Yasue H. Effects of sphingomylelinase and sphingosine on arterial vasomotor regulation. J Lipid Res. 1996;37:1601-1608.
19. Li H, Junk P, Huwiler A, Burkhardt C, Wallerath T, Pfeilschifter J, Förstermann U. Dual effect of ceramide on human endothelial cells. Circulation. 2002;106:2250-2256.
20. Bhunia AK, Han H, Snowden A, Chaterjee S. Redox-regulated signaling by lactosylceramide in the proliferation of human aortic smooth muscle cells. J Biol Chem. 1997;272:15642-15649.
21. Corda S, Laplace C, Vicaut E, Duranteau J. Rapid reactive oxygen species production by mitochondria in endothelial cells exposed to tumor necrosis factor-á is mediated by ceramide. Am J Respir Cell Mol Biol. 2001;24:762-768.
22. Arai T, Bhunia AK, Chatterjee S, Bulkley GB. Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro. Circ Res. 1998;82:540-547.
23. Garcia-Ruiz C, Colell A, Mari M, Morales A, Fernandez-Checa JC. Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. J Biol Chem. 1997;272:11369-11377.
24. Crapo JD, Oury T, Rabouille C, Slot JW, Chang L-Y. Copper, zinc superoxide dismutase is primarily a cytosolic protein in human cells. Proc Natl Acad Sci USA. 1992;89:10405-10409.
25. The Jackson Laboratory Website. Available at: http://www.jax.org. Accessed January 4, 2004.
26. Didion SP, Ryan MJ, Baumbach GL, Sigmund CD, Faraci FM. Superoxide contributes to vascular dysfunction in mice that express human renin and human angiotensinogen. Am J Physiol Mean Circ Physiol. 2002;283:H1569-H1576.
27. Didion SP, Ryan MJ, Didion LA, Fegan PE, Sigmund CD, Faraci FM. Increased superoxide and vascular dysfunction in CuZnSOD-deficient mice. Circ Res. 2002;91:938-944.
28. Lamping KG, Faraci FM. Role of sex differences and effects of endothelial NO synthase deficiency in responses of carotid arteries to serotonin. Arterioscler Thromb Vasc Biol. 2001;21:523-528.
29. Bielawska A, Crane HM, Liotta D, Obeid LM, Hannun YA. Selectivity of ceramide-mediated biology: lack of activity of erythro-dihydroceramide. J Biol Chem. 1993;268:26226-26232.
30. i in canine cerebral vascular muscle. Am J Physiol Heart Circ Physiol. 2000;278: H1421-H1428.
31. i in canine cerebral vascular smooth muscle. Neurosci Lett. 1998;256:113-116.
32. 2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J Biol Chem. 1997;272:17196-17203.
33. Guo Z, Van Remmen H, Yang H, Chen X, Mele J, Vijg J, Epstein CJ, Ho YS, Richardson A. Changes in expression of antioxidant enzymes affect cell-mediated LDL oxidation and oxidized LDL-induced apoptosis in mouse aortic cells. Arteioscler Thromb Vasc Biol. 2001;21:1131-1138.
34. Chen Z, Oberley TD, Ho YH, Chua CC, Siu B, Hamdy RC, Epstein CJ, Chua BH. Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free Radical Biol Med. 2000;29:589-596.
35. Epstein CJ, Avraham KB, Lovett M, Smith S, Elroy-Stein O, Rotman G, Bry C, Groner Y. Transgenic mice with increased Cu/Zn-superoxide dismutase activity: animal model of dosage effects in Down syndrome. Proc Natl Acad Sci USA. 1987;84:8044-8048.
36. Tribble DL, Gong EL, Leeuwenburgh C, Heinecke JW, Carlson EL, Verstuyft JG, Epstein CJ. Fatty streak formation in fat-fed mice expressing human copper-zinc superoxide dismutase. Arterioscler Thromb Vasc Biol. 1997;17:1734-1740.
37. Didion SP, Kinzenbaw DA, Fegan PE, Didion LA, Faraci FM. Overexpression of CuZn-SOD prevents lipopolysaccharide-induced endothelial dysfunction. Stroke. 2004;35:1963-1967.
38. Benov L, Sztejnberg L, Fridovich I. Critical evaluation of the use of hydroethidine as a measure of superoxide anion radical. Free Radical Biol Med. 1998;25:826-831.
39. Miller FJ Jr, Gutterman DD, Rios CD, Heistad DD, Davidson BL. Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis. Circ Res. 1998;82:1298-1305.
40. Azumi H, Inoue N, Ohashi Y, Terashima M, Mori T, Fujita H, Awano K, Kobayashi K, Maeda K, Hata K, Shinke T, Kobayashi S, Hirata K, Kawashima S, Itabe H, Hayashi Y, Imajoh-Ohmi S, Itoh H, Yokoyama M. Superoxide generation in directional coronary atherectomy specimens of patients with angina pectoris: important role of NAD(P)H oxidase. Anerioscler Thromb Vasc Biol. 2002;22:1838-1844.
41. Tarpey MM, Fridovich I. Methods of detection of vascular reactive oxygen species. Circ Res. 2001;89:224-236.
42. Tarpey MM, Wink DA, Grisham MB. Methods for detection of reactive metabolites of oxygen an nitrogen: in vitro and in vivo considerations. Am J Physiol Regul Integr Comp Physiol. 2004;286:R431-R444.
43. Münzel T, Afanas'ev IB, Kleschyov AL, Harrison DG. Detection of superoxide in vascular tissue. Arteioscler Thromb Vasc Biol. 2002;22:1761-1768.
44. Stepp DW, Ou J, Ackerman AW, Welak S, Klick D, Pritchard KA Jr. Native LDL and minimally oxidized LDL differentially regulate superoxide anion in vascular endothelium in situ. Am J Physiol Heart Circ Physiol. 2002;283:H750-H759.
45. Collado MP, Latorr E, Fernandez I, Aragones MD, Catalan RE. Brain microvessel endothelin type A receptors are coupled to ceramide production. Biochem Biophys Res Comm. 2003;306:282-285.
46. Lamping KG, Nuno DW, Chappell DA, Faraci FM. Agonist-specific impairment of coronary vascular function in genetically altered, hyperlipidemic mice. Am J Physiol. 1999;276:R1023-R1029.